MDxHealth SA (MDXH)

USD 1.57

(1.29%)

Total Assets Summary of MDxHealth SA

  • MDxHealth SA's latest annual total assets in 2023 was 129.13 Million USD , up 8.39% from previous year.
  • MDxHealth SA's latest quarterly total assets in 2024 Q2 was 130.85 Million USD , up 7.49% from previous quarter.
  • MDxHealth SA reported annual total assets of 119.13 Million USD in 2022, up 58.69% from previous year.
  • MDxHealth SA reported annual total assets of 75.07 Million USD in 2021, up 135.66% from previous year.
  • MDxHealth SA reported quarterly total assets of 130.85 Million USD for 2024 Q2, up 7.49% from previous quarter.
  • MDxHealth SA reported quarterly total assets of 135.73 Million USD for 2023 Q3, down -4.78% from previous quarter.

Annual Total Assets Chart of MDxHealth SA (2023 - 2004)

Historical Annual Total Assets of MDxHealth SA (2023 - 2004)

Year Total Assets Total Assets Growth
2023 129.13 Million USD 8.39%
2022 119.13 Million USD 58.69%
2021 75.07 Million USD 135.66%
2020 31.85 Million USD -21.59%
2019 40.62 Million USD -37.95%
2018 65.47 Million USD 11.88%
2017 58.52 Million USD -13.59%
2016 67.72 Million USD 17.28%
2015 57.74 Million USD 86.55%
2014 30.95 Million USD 5.34%
2013 29.38 Million USD 46.91%
2012 20 Million USD 5.04%
2011 19.04 Million USD -0.7%
2010 19.17 Million USD -45.93%
2009 35.46 Million USD -34.77%
2008 54.36 Million USD -6.56%
2007 58.18 Million USD 19.87%
2006 48.53 Million USD 188.76%
2005 16.8 Million USD 91.8%
2004 8.76 Million USD 0.0%

Peer Total Assets Comparison of MDxHealth SA

Name Total Assets Total Assets Difference
Aclaris Therapeutics, Inc. 197.4 Million USD 34.585%
Applied DNA Sciences, Inc. 13.65 Million USD -845.913%
Aspira Women's Health Inc. 6.26 Million USD -1962.153%
Biodesix, Inc. 99.09 Million USD -30.31%
BioNexus Gene Lab Corp. 11.39 Million USD -1032.757%
bioAffinity Technologies, Inc. 8.22 Million USD -1470.652%
bioAffinity Technologies, Inc. 8.22 Million USD -1470.652%
Bionano Genomics, Inc. 214.4 Million USD 39.772%
CareDx, Inc 484.61 Million USD 73.354%
Check-Cap Ltd. 25.01 Million USD -416.177%
Castle Biosciences, Inc. 477.81 Million USD 72.974%
DarioHealth Corp. 96.38 Million USD -33.97%
Exact Sciences Corporation 6.47 Billion USD 98.005%
Fulgent Genetics, Inc. 1.27 Billion USD 89.857%
Guardant Health, Inc. 1.78 Billion USD 92.771%
ICON Public Limited Company 16.98 Billion USD 99.24%
IDEXX Laboratories, Inc. 3.25 Billion USD 96.039%
Illumina, Inc. 10.11 Billion USD 98.723%
Intelligent Bio Solutions Inc. 13.77 Million USD -837.175%
iSpecimen Inc. 15.81 Million USD -716.302%
Standard BioTools Inc. 323.06 Million USD 60.029%
23andMe Holding Co. 395.16 Million USD 67.322%
Medpace Holdings, Inc. 1.65 Billion USD 92.206%
Myriad Genetics, Inc. 1.19 Billion USD 89.227%
Mainz Biomed B.V. 15.4 Million USD -738.028%
ENDRA Life Sciences Inc. 6.75 Million USD -1811.892%
NeoGenomics, Inc. 1.68 Billion USD 92.319%
Neogen Corporation 4.58 Billion USD 97.183%
Inotiv, Inc. 856.53 Million USD 84.924%
Natera, Inc. 1.45 Billion USD 91.138%
OpGen, Inc. 1.88 Million USD -6760.425%
OPKO Health, Inc. 2.01 Billion USD 93.581%
Psychemedics Corporation 13.27 Million USD -873.112%
Prenetics Global Limited 254.17 Million USD 49.195%
Prenetics Global Limited 254.17 Million USD 49.195%
Precipio, Inc. 18.1 Million USD -613.397%
Personalis, Inc. 225.09 Million USD 42.633%
RadNet, Inc. 2.88 Billion USD 95.527%
Sera Prognostics, Inc. 95.44 Million USD -35.3%
Sotera Health Company 3.13 Billion USD 95.875%
Neuronetics, Inc. 115.83 Million USD -11.483%
Star Equity Holdings, Inc. 86.97 Million USD -48.472%
Star Equity Holdings, Inc. 86.97 Million USD -48.472%
Trinity Biotech plc 59.43 Million USD -117.266%
T2 Biosystems, Inc. 34.79 Million USD -271.101%
Twist Bioscience Corporation 776.4 Million USD 83.368%
Exagen Inc. 56.94 Million USD -126.77%